Genetic Future
Commentary on human genetics and evolution, direct-to-consumer genetic testing, and the personal genomics industry.
Search
Profile
Daniel MacArthur
I write about the genetic and evolutionary basis of human variation, and the companies trying to sell you information about your genome.
Daniel also blogs about personal genomics at Genomes Unzipped.
Subscribe via RSS.
Follow me on Twitter.
Recent Posts
- Genetic Future is moving
- One more step towards the end of recessive diseases
- New FireFox plugin for 23andMe customers
- Why you CAN have your $1000 genome - so long as you learn what to do with it
- Bioscience Resource Project critique of modern genomics: a missed opportunity
- Genomes Unzipped reader survey
- News from 23andMe: a bigger chip, a new subscription model and another discount drive
- Why I'm releasing my genetic data online
- Oddities of the odds ratio
- Genetic Future is moving to Wired
Recent Comments
- Dan Frost on Genetic Future is moving
- Neil on One more step towards the end of recessive diseases
- Daniel MacArthur on One more step towards the end of recessive diseases
- Neil on One more step towards the end of recessive diseases
- Daniel MacArthur on One more step towards the end of recessive diseases
- Moreno on One more step towards the end of recessive diseases
- Bob on One more step towards the end of recessive diseases
- Neil on One more step towards the end of recessive diseases
- Jonathan on One more step towards the end of recessive diseases
- Daniel MacArthur on One more step towards the end of recessive diseases
Archives
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
Blogs I read:
Consumer Genomics:
Genomic Science:
- Anthony Fejes
- David Dooling
- Dan Koboldt
- Luke Jostins
- Pathogenomics
- Jan Aerts
- Popgen Ramblings
- Adaptive Complexity
- Genomicron
Genetics/Evolution Blogs:
- Razib Khan
- John Hawks
- Gene Expression
- Eye on DNA
- Dienekes
- Yann Klimentidis
- European Genetics
- Discovering Biology in a Digital World
- The Genetic Genealogist
- business|bytes|genes|molecules
- Thomas Mailund
- John Halamka
General Science:
Corporate Blogs:
Skeptics:
About Genetic Future
In around five years, a complete genome sequence will be readily affordable for most citizens of wealthy industrialised nations - even those of us on a researcher's salary. At the same time we will have access to vast amounts of data about the effects of individual genetic variants on our future health. Storing, processing and using genetic data to make effective health decisions will become an immense challenge both to healthcare providers and to individual consumers.
The revolution has already begun: right now, "personal genomics" companies such as 23andMe, deCODEme and Navigenics offer to scan your genome for hundreds of thousands of common sites of variation, and to generate predictions about your risk of common diseases such as diabetes and arthritis. A horde of smaller companies also offer "boutique" genetic testing services for anything from hair loss to bipolar disorder. Some of these tests are valuable, while for others the scientific evidence is weak and the predictive value vanishingly small - but for the typical consumer it is difficult to discern the genuine offerings from the scams.
Genetic Future's primary mission is to cut through the hype associated with the brave new world of human genomics. I report on the latest findings from genome-wide association studies and large-scale sequencing projects investigating the genetic underpinnings of common disease, putting their results in context and in language that consumers can understand.
I also review the scientific basis and useability of products offered by commercial genetic testing companies. I'll be dissecting the studies used by these companies to justify their expensive tests, and describing in plain language how useful such tests are likely to be to consumers.
About Me
I'm an Australian researcher (now based in the UK) interested in the evolutionary origins of the genetic variants that underlie normal variation and common disease risk in modern humans.
I also have a long-standing personal fascination with the consumer genetic testing industry, and particularly in the shiny new field of personal genomics. When the $1000 genome sequence arrives, I'll be buying one - and I want to know what to do with it once I have it.
My older articles on human genetics and personal genomics are archived at the old Genetic Future site.

